Research

Publications

Thesis


Publications

1-Kamali-Sarvestani E, Zolghadri J, Gharesi-Fard B, Sarvari J. Cytokine gene polymorphisms and susceptibility to recurrent pregnancy loss in Iranian women. J Reprod Immunol. 2005;65(2):171-8.

2-Amirghofran Z, BahmaniM, AzadmehrA, JavidniaK. Anticancer effects of various Iranian native medicinal plants on human tumor cell lines. Neoplasma.2006; 53(5): 428-33.

3-
Kamali-Sarvestani E, RasouliM, MortazaviH, Gharesi-FardB. Cytokine gene polymorphisms and susceptibility to cutaneousleishmaniasisin Iranianpatients.Cytokine.2006; 35(4-3):159-165.

4-
Kamali-SarvestaniE, BazarganiA, MasoudianM, LankaraniK,TaghaviAR, SaberifirooziM. Association of H pyloricagA andvacAgenotypes and IL-8 gene polymorphisms with clinical outcome of infection inIranian patients withgastrointestinal diseases. World JGastroenterol. 2006;12(32): 5205-10

5-
Kamali-Sarvestani E, KianyS, Gharesi-FardB, RobatiM. Association study of IL-10 and IFN-gamma gene polymorphisms in Iranian women with preeclampsia. JReprodImmunol. 2006 ;72(2-1); 118-26.

6-
Kamali-SarvestaniE,NiksereshtAR,AliparastiMR,VessalM.IL-8 (-251 A/T) and CXCR2 (+1208 C/T) gene polymorphisms and risk of multiplesclerosis in Iranian patients. NeurosciLett. 2006; 4(2-1): 159-62.

7-NikokarI, MakvandiM, KajbafMJ, FarajzadehA, MirsaeidiM, Kamali- SarvestaniE, MostafaieA, HuygenK. Evaluation of Cellular Immune Responseagainst Purified Antigen 85 in Patients with Tuberculosis. IJI. 2006;3(2);70-77. 

8-
Razeghinejad MR, Kamali-SarvestaniE, FarvardinM, PourhabibiA. Aqueous Levels of Anti-Helicobacter PyloriIgGAntibody in Patients with Primary Open Angle andPseudoexfoliationGlaucoma. IJI. 2006; 3(2): 86-90.   

9-
Nikseresht AR, AziziMA, Gharesi-FardB,KamaliSarvestaniE. Investigation ofFcγRIIA andFcγRIIIA Polymorphism in Multiple Sclerosis: A Case Control Study. IJI. 2006;3(3):136-141.

10-
Fani F, kamali-SarvestaniE,YazdanparastR,MonabatiA,RafieiSH.T Cell Tolerance Following BacterialGlutamicAcidDecarboxylase (GAD) Feeding inStreptozotocin-InducedDiabetes. IJI. 2006; 3(4):169-175.

11-
Namazi MR. Extension of the "Hygiene Hypothesis" to the negative associationbetween acne andatopy, hematological malignancies, and malignant melanoma. Med Hypotheses. 2007; 69(4) :960-1.

12-
Namazi MR. Glucose-6-phosphate-dehydrogenase deficiency is a possiblepredisposerto Th2-dominant disorders. Med Hypotheses.2007;68(3):720.

13-
Namazi MR. Glucose-6-phosphate-dehydrogenase deficiency is a possible risk factor for thedevelopment of toxic epidermalnecrolysis. Med Hypotheses.2007;68(2):466-7.

14-
Namazi MR. possible molecular mechanisms involved in the down-regulation of expression andactivity of inducible nitric oxidesynthasein the psoriatic lesions . Indian JDermatol.2006;51(3):194-5. 

15-
Razeghinejad MR, Kamali-SarvestaniE . he plateau iris component of primary angle closure glaucoma : Developmental oracquired. Medical hypotheses. 2007; 69(1) :95-98.

16-
Kamali-sarvestani E, FarsianiH, SHamoonPour M, BazarganiA, LankaraniK, TaghaviAR, SaberifirooziM. Association ofMyeloperoxidase-463G/A Polymorphism with Clinical outcome of Helicobacter Pylori infection inIranian Patients with Gastrointestinal Diseases. Iran.J.Immunol.2007; 4(3):155-160.

17-
Namazi MR. Increase of intracellularmethylglyoxalas a mode of action ofretinoidsagainst psoriasis. Dermatology Online Journal .2007 ; 13(2):30.

18-
Amirghofran Z,AzadmehrA,JavidniaK.HaussknechtiaElymatica: A Plant WithImmunomodulatoryEffects. Iran.J.Immunol.2007;4(1):26-31.

19-
Gharagozloo M, AmirghofranZ.Effects ofsilymarinon the spontaneous proliferation and cell cycle of human peripheral bloodleukemia T cells. J Cancer ResClinOncol. 2007;133(8):525-32.

20-
Kamali-sarvestani E,NiksereshtA,AflakiE,SarvariJ,Gharesi-FardB. TNF-alpha, TNF-beta and IL-4 gene polymorphisms in Iranian patients withmultiple sclerosis. ActaNeurolScand.2007;115(3):161-6.

21-
Kamali-sarvestani E, Ghayomi MA, Nekoee A. Association of TNF-α -308 G/A and IL-4 -589 C/T Gene Promoter Polymorphisms With Asthma Susceptibility in the South of Iran. J Investig Allergol Clin Immunol 2007;17(6):361-366.

22-
Namazi MR. Can excessive washing really be regarded as the major cause of atopic dermatitis. Trends Immunol. 2007 Nov 26; [Epub ahead of print] No abstract available

23-
Kamali-Sarvestani E, Aliparasti MR, Atefi S. Association of interleukin-8 (IL-8 or CXCL8) -251T/A and CXCR2 +1208C/T gene polymorphisms with breast cancer. Neoplasma. 2007;54(6):484-9.

24-
Gharesi-Fard B, ZolghadriJ, Kamali-Sarvestani1 E. Effect of Leukocyte Therapy on Tumor Necrosis Factor-Alpha and Interferon-Gamma Production in Patients with Recurrent
Spontaneous Abortion. Am J Reprod immunol 2008; 59: 242-250.

25-
Amirghofran Z, Bahmani M, Azadmehr A, Ashouri E, Javidnia K. Antitumor activity and apoptosis induction in human cancer cell lines by Dionysia termeana. Cancer Invest. 2007 Oct; 25(7): 550-4.
Association of interferon-gamma and tumor necrosis factor alpha polymorphisms with susceptibility to vitiligo in Iranian patients. Arch Dermatol Res. 2008 Sep 27.

27-
Mojtahedi Z, Clos J, Kamali-Sarvestani E.Leishmania major: identification of developmentally regulated proteins in procyclic and metacyclic promastigotes.Exp Parasitol. 2008 Jul;119(3):422-9.

28-
Gharagozloo M, Karimi M, Amirghofran Z.Double-faced cell-mediated immunity in beta-thalassemia major: stimulated phenotype versus suppressed activity.Ann Hematol. 2008 Aug 9.

29-
Faham N, Javidnia K, Bahmani M, Amirghofran Z.Calycopterin, an immunoinhibitory compound from the extract of Dracocephalum kotschyi. Phytother Res. 2008 Sep;22(9):1154-8

30-
Amirghofran Z, Azadmehr A, Bahmani M, Javidnia K. Stimulatory effects of Euphorbia cheiradenia on cell mediated immunity and humoral antibody synthesis. Iran J Immunol. 2008 Jun;5(2):115-23.

31-
Gharagozloo M, Khoshdel Z, Amirghofran Z. The effect of an iron (III) chelator, silybin, on the proliferation and cell cycle of Jurkat cells: a comparison with desferrioxamine.Eur J Pharmacol. 2008 Jul 28;589(1-3):1-7. Epub 2008 Apr 6.

32-
Naghibalhossaini F, Mokarram P, Khalili I. Easy detection of 5,10-methylenetetrahydrofolate reductase 1298A/C genotype by mutagenically separated PCR assay.Clin Chem Lab Med. 2008;46(7):987-9

33-
Namazi MR. Which cyclic antidepressants are superior for the treatment of depressed psoriatic patients? A theoretical molecular approach. Dermatol Online J. 2008 Jan 15;14(1):23.

34-
Jahadi Hosseini HR, Kamali Sarvestani E, Akbari M, Mosallaei M. Effect of fas -670 a/g gene polymorphism on corneal allograft endothelial rejection.Iran J Immunol. 2009 Mar;6(1):28-32.

35-
Razeghinejad MR, Rahat F, Kamali-Sarvestani E. Association of TNFA -308 G/A and TNFRI +36 A/G Gene Polymorphisms with Glaucoma.Ophthalmic Res. 2009 Jun 24;42(3):118-124.

36-
Gharagozloo M, Karimi M, Amirghofran Z. Double-faced cell-mediated immunity in beta-thalassemia major: stimulated phenotype versus suppressed activity. Ann Hematol. 2009 Jan;88(1):21-7. Epub 2008 Aug 9.

37-
Amirghofran Z, Bahmani M, Azadmehr A, Javidnia K, Miri R. Immunomodulatory activities of various medicinal plant extracts: effects on human lymphocytes apoptosis.Immunol Invest. 2009;38(2):181-92.

38-
Azadmehr A, Pourfathollah AA, Amirghofran Z, Hassan ZM, Moazzeni SM. Enhancement of Th1 immune response by CD8alpha(+) dendritic cells loaded with heat shock proteins enriched tumor extract in tumor-bearing mice. Cell Immunol. 2009;260(1):28-32. Epub 2009 Aug 3.

39-
Yeganeh F, Barkhordari F, Omidi M, Samiei A, Adeli A, Mahboudi F, Kamali-Sarvestani E.Cloning and Expression of Leishmania major Superoxide Dismutase B1: A Potential Target Antigen for Serodiagnosis of Leishmaniasis.Iran J Immunol. 2009 Sep;6(3):130-40.

40-
Namazi MR, Fallahzadeh MK, Shaghelani H, Kamali-Sarvestani E. Marked elevation of serum macrophage migration inhibitory factor levels in patients with pemphigus vulgaris. Int J Dermatol. 2009 Oct 1.

41-
Fallahzadeh M.K., Borhani Haghighi A, Namazi M.R. Proton pump inhibitors: predisposers to Alzheimer disease? Journal of clinical pharmacy and therapeutics (2009)34,1-2.

42-
Gharesi-Fard B, Zolghadri J, Kamali-Sarvestani E. Proteome Differences of Placenta Between Pre-Eclampsia and Normal Pregnancy.Placenta. 2010 Feb;31(2):121-125. Epub 2009 Dec 1.

43-
Fallahzadeh MK, Lashkarizadeh H, Kamali-Sarvestani E, Namazi MR. Elevation of serum prolactin levels in patients with pemphigus vulgaris: a novel finding with practical implications. J Am Acad Dermatol. 2010 Jun;62(6):1071-2.

44-
Bazargani A, Khoramrooz SS, Kamali-Sarvestani E, Taghavi SA, Saberifiroozi M. Association between peroxisome proliferator-activated receptor-γ gene polymorphism (Pro12Ala) and Helicobacter pylori infection in gastric carcinogenesis.Scand J Gastroenterol. 2010 Oct;45(10):1162-7.

45-
Jamshidian A, Nikseresht AR, Vessal M, Kamali-Sarvestani E. Association of CD1A +622 T/C, +737 G/C and CD1E +6129 A/G genes polymorphisms with multiple sclerosis. Immunol Invest. 2010;39(8):874-89.

46-
Zoghi S, Amirghofran Z, Nikseresht A, Ashjazadeh N, Kamali-Sarvestani E, Rezaei N.Cytokine secretion pattern in treatment of lymphocytes of multiple sclerosis patients with fumaric acid esters. Immunol Invest. 2011;40(6):581-96. Epub 2011 Apr 21.

47-
Danesh-Bahreini MA, Shokri J, Samiei A, Kamali-Sarvestani E, Barzegar-Jalali M, Mohammadi-Samani S.Nanovaccine for leishmaniasis: preparation of chitosan nanoparticles containing Leishmania superoxide dismutase and evaluation of its immunogenicity in BALB/c mice. Int J Nanomedicine. 2011;6:835-42. Epub 2011 Apr 20.

48-
Kalantari T, Kamali-Sarvestani E, Ciric B, Karimi MH, Kalantari M, Faridar A, Xu H, Rostami A.Generation of immunogenic and tolerogenic clinical-grade dendritic cells. Immunol Res. 2011 Dec;51(2-3):153-60.

50-
Fathi M, Amirghofran Z, Shahriari M.Soluble Fas and Fas ligand and prognosis in children with acute lymphoblastic leukemia. Med Oncol. 2012 Sep;29(3):2046-52.

51-
Amirghofran Z, Bahmani M, Azadmehr A, Javidnia K, Ramazani M, Ziaei A. Effect of Salvia mirzayanii on the immune system and induction of apoptosis in peripheral blood lymphocytes.Nat Prod Res. 2010 Apr;24(6):500-8.

52-
Naghibalhossaini F, Zamani M, Mokarram P, Khalili I, Rasti M, Mostafavi-Pour Z.Epigenetic and genetic analysis of WNT signaling pathway in sporadic colorectal cancer patients from Iran.Mol Biol Rep. 2012 May;39(5):6171-8. Epub 2011 Dec 30.

53-
Pakdel A, Naghibalhossaini F, Mokarram P, Jaberipour M, Hosseini A.Regulation of carcinoembryonic antigen release from colorectal cancer cells. Mol Biol Rep. 2012 Apr;39(4):3695-704. Epub 2011 Jul 2.

55-
Soltani MH, Kalantari T, Karimi MH, Erfani N, Kamali Sarvestani E.Evaluation of the immunomodulatory effect of curdlan on maturation and function of mouse spleen-derived dendritic cells.Iran J Immunol. 2012 Sep;9(3):168-74.

56- Ataollahi MR, Aflaki E, Nazarinia MA, Shenavandeh S, Habibagahi Z, Gharesi-Fard B, Kamali-Sarvestani E.Anti-cardiolipin and anti-Neutrophil Cytoplasmic Antibodies in Iranian patients with Behcet's disease.Iran J Immunol. 2012 Dec;9(4):241-7

57- Gharesi-Fard B, Jafarzadeh L, Ghaderi-shabankareh F, Zolghadri J, Kamali-Sarvestani E.Presence of autoantibody against two placental proteins, peroxiredoxin 3 and peroxiredoxin 4, in sera of recurrent pregnancy loss patients. Am J Reprod Immunol. 2013 Mar;69(3):248-55.

58- Kalantari T, Kamali-Sarvestani E, Zhang GX, Safavi F, Lauretti E, Khedmati ME, Rostami A.Generation of large numbers of highly purified dendritic cells from bone marrow progenitor cells after co-culture with syngeneic murine splenocytes.Exp Mol Pathol. 2013 Apr;94(2):336-42

59- Nazarinia M, Shams M, Kamali sarvestani E, Shenavande S, Khademalhosseini M, Khademalhossaini Z. Serum homocystein level in patients with scleroderma. Iran Red Crescent Med J. 2013 Jan:15(1):29-31.

60- Hejr S, Karimi MH, Yaghobi R, Kamali sarvestani E, Geramizadeh B, Roozbeh J. Association of IL-17, IL-21 and IL-23R gene polymorphisms with HBV infection in kidney transplant patients. Viral Immunol.2013 Jun;26(3):201-6

61- Golmoghaddam H, Amirghofran Z, Aflaki E, Kamali-Sarvestani E, Shabani M, Esmaeilbeig M, Rajabi M.Association of FCRL3 genotypes with susceptibility of Iranian patients to rheumatoid arthritis. Immunol Invest. 2013;42(4):296-306.

62- Ashrafi H, Amini M, Mohammadi-Samani S, Ghasemi Y, Azadi A, Tabandeh MR, Kamali-Sarvestani E, Daneshamouz S. Nanostructure L-asparaginase-fatty acid bioconjugate: synthesis, preformulation study and biological assessment. Int J Biol Macromol. 2013 Nov;62:180-7

63- Hajizadeh MR, Mokarram P, Kamali Sarvestani E, Bolhassani A, Mostafavi Pour Z. Recombinant Nonstructural 3 Protein, rNS3, of Hepatitis C Virus Along With Recombinant GP96 Induce IL-12, TNFα and α5integrin Expression in Antigen Presenting Cells. Hepat Mon. 2013 Jun 3;13(6).

64- Karamizadeh Z, Kamali sarvestani E, Saki F, Karamifar H, Amirhakimi GH, Namavar shooshtarian MH, Ashkani-Esfahani S. Investigation of osteopontin levels and genomic variation of osteopontin and its receptors in Type 1 diabetes mellitus. J Endocrinol Invest.2013 Dec; 36(11):1090-3.

65- Karimi MH, Hejr S, Geramizadeh B, Yaghobi R, Sagheb MM, Kamali-Sarvestani E. Combined analysis of cytokine gene polymorphism and the level of expression with allograft function in kidney transplant recipients. Transpl Immunol. 2014 Jan;30(1):46-51

66- Karimi MH, Hejr S, Geramizadeh B, Nikeghbalian S, Kamali-Sarvestani E, Yaghobi R. Study of the relationships between IL-23R, IL-17, IL-21 polymorphisms and serum level of IL-17, IL-21 with acute graft rejection in iranian liver transplant recipients. Immunol Invest. 2014;43(1):69-85

67- Kalantari T, Karimi MH, Ciric B, Yan Y, Rostami A, Kamali-Sarvestani E.Tolerogenic dendritic cells produced by lentiviral-mediated CD40- and interleukin-23p19-specific shRNA can ameliorate experimental autoimmune encephalomyelitis by suppressing T helper type 17 cells. Clin Exp Immunol. 2014 May;176(2):180-9.

68- Tolide-Ie H, Tabatabaee HR, Kamali-Sarvestani E. Association between Tumor Necrosis Factor- α-308 G/A Polymorphism and Multiple Sclerosis: A Systematic Review and Meta-Analysis. Iran J Med Sci. 2014 Jan;39(1):2-10.

69- Gharesi-Fard B, Zolghadri J, Kamali-Sarvestani E. Alteration in the expression of proteins in unexplained recurrent pregnancy loss compared with in the normal placenta. J Reprod Dev. 2014;60(4):261-7.

70- Nazarinia M, Jalli R, Kamali Sarvestani E, Farahangiz S, Ataollahi M. Asymptomatic atlantoaxial subluxation in rheumatoid arthritis. Acta Med Iran. 2014;52(6):462-6.

71- Sadeghi L, Kamali-Sarvestani E, Azarpira N, Shariati M, Karimi MH. Immunomodulatory effects of mice mesenchymal stem cells on maturation and activation of dendritic cells. Iran J Immunol. 2014 Sep;11(3):177-88.

72- Dabagh-Gorjani F, Anvari F, Zolghadri J, Kamali-Sarvestani E, Gharesi-Fard B. Differences in the expression of TLRs and inflammatory cytokines in pre-eclamptic compared with healthy pregnant women. Iran J Immunol. 2014 Dec;11(4):233-45

73- Mohtasebi MS, Nasri F, Kamali Sarvestani E. Effect of DiD Carbocyanine Dye Labeling on Immunoregulatory Function and Differentiation of Mice Mesenchymal Stem Cells. Stem Cells Int. 2014;2014:457614.

74- Varedi M, Shiri H, Moattari A, Omrani GH, Amirghofran Z. Hyperthyroid state or in vitro thyroxine treatment modulates TH1/TH2 responses during exposure to HSV-1 antigens. J Immunotoxicol. 2014 Apr-Jun;11(2):160-5.

75- Bordbar N, Karimi MH, Amirghofran Z. Phenotypic and functional maturation of murine dendritic cells induced by 18 alpha- and beta-glycyrrhetinic acid. Immunopharmacol Immunotoxicol. 2014 Feb;36(1):52-60.

76- Karimi MH, Ebrahimnezhad S, Namayandeh M, Amirghofran Z1. The effects of cichorium intybus extract on the maturation and activity of dendritic cells. Daru. 2014 Feb 24;22(1):28.

77- Karimian P, Kavoosi G, Amirghofran Z. Anti-oxidative and anti-inflammatory effects of tagetes minuta essential oil in activated macrophages. Asian Pac J Trop Biomed.2014 Mar;4(3):219-27.

78- M Kamazani F, Bahoush-Mehdiabadi G, Aghaeipour M, Vaeli S, Amirghofran Z. The Expression and Prognostic Impact of CD95 Death Receptor and CD20, CD34 and CD44 Differentiation Markers in Pediatric Acute Lymphoblastic Leukemia.Iran J Pediatr. 2014 Aug;24(4):371-80.

79- Association Between MTHFR Genetic Variants and Multiple Sclerosis in a Southern Iranian Population.Naghibalhossaini F1, Ehyakonandeh H2, Nikseresht A3, Kamali E3. 2015 Spring;4(2):87-93

80-The Prevalence of Thyroid Dysfunction in Patients With Systemic Lupus Erythematosus. Rasaei N, Shams M, Kamali-Sarvestani E, Nazarinia MA. Iran Red Crescent Med J. 2015 Dec 5;17(12):e17298. doi: 10.5812/ircmj.17298. eCollection 2015 Dec.

81-Serum Levels of Monocyte Chemoattractant Protein-1 Correlate with Poor Clinical Grades in Cerebral Aneurysms.Rahmanian A, Mohebali N, Haghnegahdar A, Kamali Sarvestani E, Razmkon A, Kivelev J, Baghban F.Iran J Immunol. 2015 Dec;12(4):302-10.

82-Investigating the Association of IL-17A and IL-17F with Susceptibility to Pre-eclampsia in Iranian Women.Anvari F, Dabagh-Gorjani F, Soltani-Zangbar MS, Kamali-Sarvestani E, Malek-Hosseini Z, Gharesi-Fard B.Iran J Immunol. 2015 Jun;12(2):117-28

83-Stealth Nanogels of Histinylated Poly Ethyleneimine for Sustained Delivery of Methotrexate in Collagen-Induced Arthritis Model.Abolmaali S, Tamaddon A, Kamali-Sarvestani E, Ashraf M, Dinarvand R.Pharm Res. 2015 Oct;32(10):3309-23.. Epub 2015 May 12.

84- DNMT3b -149C/T promoter variants and methylation of colorectal cancer-associated genes..Naghibalhossaini F1,2, Mokarram P1, Khalili E1, Naghibalhossaini S1. Cancer Biomark. 2015;15(3):227-33

85- Expression Profile of Human Fc Receptor-Like 1, 2, and 4 Molecules in Peripheral Blood Mononuclear Cells of Patients with Hashimoto's Thyroiditis and Graves' Disease.Rostamzadeh D1, Dabbaghmanesh MH2, Shabani M3, Hosseini A1, Amirghofran Z1. Horm Metab Res. 2015 Aug;47(9):693-8. Epub 2015 Mar 4.

86- Inhibition of CEA release from epithelial cells by lipid A of Gram-negative bacteria Naghibalhossaini F, Sayadi K, Jaberie H, Bazargani A, Eftekhar E, Hosseinzadeh M. Cell Mol Biol Lett. 2015 Sep;20(3):374-84.

87- Modulatory effects of thymol and carvacrol on inflammatory transcription factors in lipopolysaccharide-treated macrophages. Gholijani N1, Gharagozloo M2,3, Farjadian S1, Amirghofran Z1,4.J Immunotoxicol. 2016 Mar;13(2):157-64. Epub 2015 Mar 27.

88- Modulation of Cytokine Production and Transcription Factors Activities in Human Jurkat T Cells by Thymol and Carvacrol. Gholijani N1, Gharagozloo M2, Kalantar F3, Ramezani A4, Amirghofran Z5. Adv Pharm Bull. 2015 Dec;5(Suppl 1):653-60 Epub 2015 Dec 31

89- Effects of Eccentric and Concentric Emphasized Resistance Exercise on IL-15 Serum Levels and Its Relation to Inflammatory Markers in Athletes and Non-Athletes . Bazgir B1, Salesi M2, Koushki M2, Amirghofran Z3.

Asian J Sports Med. 2015 Sep;6(3): Epub 2015 Sep 28..

90- The effect of dimethyl fumarate on gene expression and the level of cytokines related to different T helper cell subsets in peripheral blood mononuclear cells of patients with psoriasis.Tahvili S1, Zandieh B2, Amirghofran Z1,3. Int J Dermatol. 2015 Jul;54(7):e254-60.

91-.Inhibition of CEA release from epithelial cells by lipid A of Gram-negative bacteria.Naghibalhossaini F, Sayadi K, Jaberie H, Bazargani A, Eftekhar E, Hosseinzadeh M. Cell Mol Biol Lett. 2015 Sep;20(3):374-84

92- Rezaei N, Amirghofran Z, Nikseresht A, Ashjazade N, Zoghi S, Tahvili S, Kamali-Sarvestani E. In Vitro Effects of Sodium Benzoate on Th1/Th2 Deviation in Patients with Multiple Sclerosis. Immunol Invest. 2016 Oct;45(7):679-91.

93- Peiravian F, Rajaian H, Samiei A, Gholijani N, Gharesi-Fard B, Mokaram P, Rahimi-Jaberi A, Kamali Sarvestani E. Altered Serum Cytokine Profiles in Relapse Phase of Relapsing-Remitting Multiple Sclerosis. Iran J Immunol. 2016 Sep;13(3):186-96.

94- Salimeh Ebrahimnezhad, Zahra Amirghofran, Mohammad Hossein Karimi.Decline in Immunological Responses Mediated by Dendritic Cells in Mice Treated with 18α-Glycyrrhetinic Acid. IMMUNOLOGICAL INVESTIGATIONS. 2016, VOL. 45, NO. 3, 191–204

95- Gholijani N, Amirghofran Z. Effects of thymol and carvacrol on T-helper cell subset cytokines and their main transcription factors in ovalbumin-immunized mice.J Immunotoxicol. 2016 Sep;13(5):729-37

96- Khanzadeh A, Habibagahi Z, Hosseini A, Amirghofran Z. Investigation of the human FCRL1, 2, and 4 gene expressions in patients with rheumatoid arthritis. Rheumatol Int. 2016 Aug;36(8):1149-56.

97- Malek-Hosseini Z, Khezri A, Amirghofran Z. Circulating Levels of M30 and M65 Molecules in Transitional Cell Carcinoma of the Bladder and Their Relation to Tumor Progression. Iran J Cancer Prev. 2016 Apr 24;9(2)

98- Zareinejad M, Samiei A, Valibeigi B, Gholami T, Zareifar S, Amirghofran Z. Interleukin-23 Receptor Gene Variants in Acute Lymphoblastic Leukemia and Their Relation to Prognostic Factors. Iran J Immunol. 2017 Mar;14(1):59-72.

99- Amirghofran Z, Ahmadi H, Karimi MH, Kalantar F, Gholijani N, Malek-Hosseini Z. In vitro inhibitory effects of thymol and carvacrol on dendritic cell activation and function. Pharm Biol. 2016 Jul;54(7):1125-32.

100- Jaberie H, Naghibalhossaini F. Recombinant production of native human α-1-antitrypsin protein in the liver HepG2 cells. Biotechnol Lett. 2016 Oct;38(10):1683-90

101- Eftekhar E, Jaberie H, Naghibalhossaini F. Carcinoembryonic Antigen Expression and Resistance to Radiation and 5-Fluorouracil-Induced Apoptosis and Autophagy.Int J Mol Cell Med. 2016 Spring;5(2):80-9.

 

 
 

 
Autoimmune Diseases Research Center
Shiraz Medical School, karimkhan-zand Blvd. Shiraz 71345-3343, Iran.
Tel: +987112357181
Fax: +987112357181
Email:
adrc@Sums.ac.ir